Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications

Testing novel drugs on fellow human beings is fraught with potential ethical concerns; however, developing drugs to treat the wide spectrum of human diseases and disorders is a moral imperative. How do we best navigate the balance between protecting the individual vs. the greater good? Global govern...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and translational science 2019-07, Vol.12 (4), p.334-342
Main Authors: Chiodin, Davy, Cox, Erica M., Edmund, Anita V., Kratz, Erica, Lockwood, Sarah H.
Format: Article
Language:English
Subjects:
Annual reports
Clinical trials
Corporate sponsorship
Documentation
Drugs
Experiments
FDA approval
Food
Global health
Human subjects
Medical research
Patient safety
Regulatory agencies
Studies
Tutorial
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53
cites cdi_FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53
container_end_page 342
container_issue 4
container_start_page 334
container_title Clinical and translational science
container_volume 12
creator Chiodin, Davy
Cox, Erica M.
Edmund, Anita V.
Kratz, Erica
Lockwood, Sarah H.
description Testing novel drugs on fellow human beings is fraught with potential ethical concerns; however, developing drugs to treat the wide spectrum of human diseases and disorders is a moral imperative. How do we best navigate the balance between protecting the individual vs. the greater good? Global government regulatory bodies are accountable for ensuring that medical experiments on human subjects are appropriately justified and subject to close oversight. In this article, we focus on two major global health authorities, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and the path to legally treating humans with new investigational products.
doi_str_mv 10.1111/cts.12635
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f928be5e03ca464a8b9a047fd544d10e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f928be5e03ca464a8b9a047fd544d10e</doaj_id><sourcerecordid>2265757798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53</originalsourceid><addsrcrecordid>eNp1kktrGzEUhYfS0qRpF_0DRdBNu3AijR4jdVEw7iOGkELrrsUdjWYqI49caSbB_76yJzFJIVroce7Rx-VyiuItweckrwszpHNSCsqfFaek4uVMYlE-P945OylepbTGWFAh-cvihGIpGVHqtNj8tN3oYQhxh-ZtCy4mRDD5hJb9EEMzmsGFHg0hv29sGlwHewE8ura36EscOzTfbr0zBzkh6Bu08K7Pgker6PL-sP66eNGCT_bN3XlW_P72dbW4nF39-L5czK9mhmPFZ8xC1QCuGbW4ZSWWtVRKWctIQxlQWbe1UkJhsKYiBDelrBnjIOoKVIVbTs-K5cRtAqz1NroNxJ0O4PRBCLHTEAdnvNWtyr8tt5gaYIKBrBVgVrUNZ6wh2GbW54m1HeuNbYzNgwH_CPq40rs_ugs3WghRUikz4MMdIIa_Yx6i3rhkrPfQ2zAmXRLFCCOU4Gx9_591HcaYx51dpeAVryq1B36cXCaGlKJtj80QrPeB0DkQ-hCI7H33sPuj8z4B2XAxGW6dt7unSXqx-jUh_wE8qsBf</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2265757798</pqid></control><display><type>article</type><title>Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chiodin, Davy ; Cox, Erica M. ; Edmund, Anita V. ; Kratz, Erica ; Lockwood, Sarah H.</creator><creatorcontrib>Chiodin, Davy ; Cox, Erica M. ; Edmund, Anita V. ; Kratz, Erica ; Lockwood, Sarah H.</creatorcontrib><description>Testing novel drugs on fellow human beings is fraught with potential ethical concerns; however, developing drugs to treat the wide spectrum of human diseases and disorders is a moral imperative. How do we best navigate the balance between protecting the individual vs. the greater good? Global government regulatory bodies are accountable for ensuring that medical experiments on human subjects are appropriately justified and subject to close oversight. In this article, we focus on two major global health authorities, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and the path to legally treating humans with new investigational products.</description><identifier>ISSN: 1752-8054</identifier><identifier>EISSN: 1752-8062</identifier><identifier>DOI: 10.1111/cts.12635</identifier><identifier>PMID: 30884199</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Annual reports ; Clinical trials ; Corporate sponsorship ; Documentation ; Drugs ; Experiments ; FDA approval ; Food ; Global health ; Human subjects ; Medical research ; Patient safety ; Regulatory agencies ; Studies ; Tutorial</subject><ispartof>Clinical and translational science, 2019-07, Vol.12 (4), p.334-342</ispartof><rights>2019 Denali Therapeutics Inc. published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.</rights><rights>2019 Denali Therapeutics Inc. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53</citedby><cites>FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2265757798/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2265757798?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30884199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiodin, Davy</creatorcontrib><creatorcontrib>Cox, Erica M.</creatorcontrib><creatorcontrib>Edmund, Anita V.</creatorcontrib><creatorcontrib>Kratz, Erica</creatorcontrib><creatorcontrib>Lockwood, Sarah H.</creatorcontrib><title>Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications</title><title>Clinical and translational science</title><addtitle>Clin Transl Sci</addtitle><description>Testing novel drugs on fellow human beings is fraught with potential ethical concerns; however, developing drugs to treat the wide spectrum of human diseases and disorders is a moral imperative. How do we best navigate the balance between protecting the individual vs. the greater good? Global government regulatory bodies are accountable for ensuring that medical experiments on human subjects are appropriately justified and subject to close oversight. In this article, we focus on two major global health authorities, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and the path to legally treating humans with new investigational products.</description><subject>Annual reports</subject><subject>Clinical trials</subject><subject>Corporate sponsorship</subject><subject>Documentation</subject><subject>Drugs</subject><subject>Experiments</subject><subject>FDA approval</subject><subject>Food</subject><subject>Global health</subject><subject>Human subjects</subject><subject>Medical research</subject><subject>Patient safety</subject><subject>Regulatory agencies</subject><subject>Studies</subject><subject>Tutorial</subject><issn>1752-8054</issn><issn>1752-8062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kktrGzEUhYfS0qRpF_0DRdBNu3AijR4jdVEw7iOGkELrrsUdjWYqI49caSbB_76yJzFJIVroce7Rx-VyiuItweckrwszpHNSCsqfFaek4uVMYlE-P945OylepbTGWFAh-cvihGIpGVHqtNj8tN3oYQhxh-ZtCy4mRDD5hJb9EEMzmsGFHg0hv29sGlwHewE8ura36EscOzTfbr0zBzkh6Bu08K7Pgker6PL-sP66eNGCT_bN3XlW_P72dbW4nF39-L5czK9mhmPFZ8xC1QCuGbW4ZSWWtVRKWctIQxlQWbe1UkJhsKYiBDelrBnjIOoKVIVbTs-K5cRtAqz1NroNxJ0O4PRBCLHTEAdnvNWtyr8tt5gaYIKBrBVgVrUNZ6wh2GbW54m1HeuNbYzNgwH_CPq40rs_ugs3WghRUikz4MMdIIa_Yx6i3rhkrPfQ2zAmXRLFCCOU4Gx9_591HcaYx51dpeAVryq1B36cXCaGlKJtj80QrPeB0DkQ-hCI7H33sPuj8z4B2XAxGW6dt7unSXqx-jUh_wE8qsBf</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Chiodin, Davy</creator><creator>Cox, Erica M.</creator><creator>Edmund, Anita V.</creator><creator>Kratz, Erica</creator><creator>Lockwood, Sarah H.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>201907</creationdate><title>Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications</title><author>Chiodin, Davy ; Cox, Erica M. ; Edmund, Anita V. ; Kratz, Erica ; Lockwood, Sarah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Annual reports</topic><topic>Clinical trials</topic><topic>Corporate sponsorship</topic><topic>Documentation</topic><topic>Drugs</topic><topic>Experiments</topic><topic>FDA approval</topic><topic>Food</topic><topic>Global health</topic><topic>Human subjects</topic><topic>Medical research</topic><topic>Patient safety</topic><topic>Regulatory agencies</topic><topic>Studies</topic><topic>Tutorial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiodin, Davy</creatorcontrib><creatorcontrib>Cox, Erica M.</creatorcontrib><creatorcontrib>Edmund, Anita V.</creatorcontrib><creatorcontrib>Kratz, Erica</creatorcontrib><creatorcontrib>Lockwood, Sarah H.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical and translational science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiodin, Davy</au><au>Cox, Erica M.</au><au>Edmund, Anita V.</au><au>Kratz, Erica</au><au>Lockwood, Sarah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications</atitle><jtitle>Clinical and translational science</jtitle><addtitle>Clin Transl Sci</addtitle><date>2019-07</date><risdate>2019</risdate><volume>12</volume><issue>4</issue><spage>334</spage><epage>342</epage><pages>334-342</pages><issn>1752-8054</issn><eissn>1752-8062</eissn><abstract>Testing novel drugs on fellow human beings is fraught with potential ethical concerns; however, developing drugs to treat the wide spectrum of human diseases and disorders is a moral imperative. How do we best navigate the balance between protecting the individual vs. the greater good? Global government regulatory bodies are accountable for ensuring that medical experiments on human subjects are appropriately justified and subject to close oversight. In this article, we focus on two major global health authorities, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and the path to legally treating humans with new investigational products.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>30884199</pmid><doi>10.1111/cts.12635</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1752-8054
ispartof Clinical and translational science, 2019-07, Vol.12 (4), p.334-342
issn 1752-8054
1752-8062
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f928be5e03ca464a8b9a047fd544d10e
source Wiley Online Library Open Access; Publicly Available Content Database; PubMed Central
subjects Annual reports
Clinical trials
Corporate sponsorship
Documentation
Drugs
Experiments
FDA approval
Food
Global health
Human subjects
Medical research
Patient safety
Regulatory agencies
Studies
Tutorial
title Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A39%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulatory%20Affairs%20101:%20Introduction%20to%20Investigational%20New%20Drug%20Applications%20and%20Clinical%20Trial%20Applications&rft.jtitle=Clinical%20and%20translational%20science&rft.au=Chiodin,%20Davy&rft.date=2019-07&rft.volume=12&rft.issue=4&rft.spage=334&rft.epage=342&rft.pages=334-342&rft.issn=1752-8054&rft.eissn=1752-8062&rft_id=info:doi/10.1111/cts.12635&rft_dat=%3Cproquest_doaj_%3E2265757798%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5095-4ea7da0b43e0f4208b8999ee41d34a38bfb99690aec7110d28b445a6b7a970f53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2265757798&rft_id=info:pmid/30884199&rfr_iscdi=true